Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
Authors
Keywords
-
Journal
BIOINORGANIC CHEMISTRY AND APPLICATIONS
Volume 2018, Issue -, Pages 1-18
Publisher
Hindawi Limited
Online
2018-10-02
DOI
10.1155/2018/8276139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug
- (2018) Keefe Guang Zhi Lee et al. ChemMedChem
- Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues
- (2018) Xiaochao Huang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Theranostic Pt(IV) Conjugate with Target Selectivity for Androgen Receptor
- (2018) Xiaodong Qin et al. INORGANIC CHEMISTRY
- Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria
- (2018) Hong Chen et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a “joint action” mode toward DNA
- (2017) Xiaodong Qin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mono-functionalized glycosylated platinum(IV) complexes possessed both pH and redox dual-responsive properties: Exhibited enhanced safety and preferentially accumulated in cancer cells in vitro and in vivo
- (2017) Jing Ma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance
- (2017) Weiwei Hu et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?
- (2017) Mauro Ravera et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Biotinylated platinum(IV) complexes designed to target cancer cells
- (2017) Jian Zhao et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Antitumor platinum(IV) derivatives of carboplatin and the histone deacetylase inhibitor 4-phenylbutyric acid
- (2017) Awatif Rashed Z. Almotairy et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Glycosylated Platinum(IV) Complexes as Substrates for Glucose Transporters (GLUTs) and Organic Cation Transporters (OCTs) Exhibited Cancer Targeting and Human Serum Albumin Binding Properties for Drug Delivery
- (2017) Jing Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hybrid of DNA-targeting Chlorambucil with Pt(IV) Species to Reverse Drug Resistance
- (2017) Feihong Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Inflammasomes in Inflammation-Induced Cancer
- (2017) Chu Lin et al. Frontiers in Immunology
- A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
- (2016) Zhigang Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia
- (2016) Wen Lv et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Trans-platinum(II)/(IV) Complexes with Acetylpyridine Ligands as Antivascular Agents in vitro: Cytotoxic and Antiangiogenic Potential
- (2016) Filipovi| Lana et al. Anti-Cancer Agents in Medicinal Chemistry
- Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action
- (2016) Xiaochao Huang et al. BIOCONJUGATE CHEMISTRY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Platinum(iv) anticancer prodrugs – hypotheses and facts
- (2016) Dan Gibson DALTON TRANSACTIONS
- Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects
- (2016) Jing Ma et al. DALTON TRANSACTIONS
- Insights into the anti-angiogenic properties of phosphaplatins
- (2016) Lu Yang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin
- (2016) Juraj Zajac et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with ‘humanized’ antigen presentation as a new preclinical study tool
- (2016) Niels A. W. Lemmermann et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression
- (2016) Jiandong Chen Cold Spring Harbor Perspectives in Medicine
- A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases
- (2015) Jana Kasparkova et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
- (2015) Vojtech Novohradsky et al. BIOCHEMICAL PHARMACOLOGY
- Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(iv) prodrug with unique mode of action
- (2015) Lili Ma et al. CHEMICAL COMMUNICATIONS
- An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: synthesis and photoactivation studies
- (2015) Albert Gandioso et al. CHEMICAL COMMUNICATIONS
- Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients?
- (2015) Marcus Schlemmer et al. CLINICAL NUTRITION
- Integrin-targeted delivery into cancer cells of a Pt(iv) pro-drug through conjugation to RGD-containing peptides
- (2015) Anna Massaguer et al. DALTON TRANSACTIONS
- Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity
- (2015) Alexey A. Nazarov et al. DALTON TRANSACTIONS
- The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells
- (2015) TOMAS GROH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery
- (2015) Franco M. Muggia et al. JOURNAL OF CLINICAL ONCOLOGY
- Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules
- (2015) Min Soo Kim et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Cancer: Mitochondrial Origins
- (2015) George B. Stefano et al. MEDICAL SCIENCE MONITOR
- Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
- (2014) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
- (2014) Rakesh K. Pathak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
- (2014) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
- (2014) Joshua Ko et al. CURRENT MEDICINAL CHEMISTRY
- Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
- (2014) Elisabetta Gabano et al. DALTON TRANSACTIONS
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
- (2014) Vojtech Novohradsky et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Reprogramming the Mechanism of Action of Chlorambucil by Coupling to a G-Quadruplex Ligand
- (2014) Marco Di Antonio et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
- (2014) Mathias Gehrmann et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy
- (2013) Kogularamanan Suntharalingam et al. CHEMICAL COMMUNICATIONS
- Glutamine and cancer: cell biology, physiology, and clinical opportunities
- (2013) Christopher T. Hensley et al. JOURNAL OF CLINICAL INVESTIGATION
- Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
- (2013) Manuela Alessio et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A Selective Mitochondrial-Targeted Chlorambucil with Remarkable Cytotoxicity in Breast and Pancreatic Cancers
- (2013) Melissa Millard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effects of light-activated diazido-PtIV complexes on cancer cells in vitro
- (2013) P. J. Bednarski et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
- (2012) Nora Graf et al. ACS Nano
- Expression of glucose transporters in cancers
- (2012) Leszek Szablewski BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
- (2012) Nora Graf et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Suberoyl bishydroxamic acid-induced apoptosis in HeLa cells via ROS-independent, GSH-dependent manner
- (2012) Bo Ra You et al. MOLECULAR BIOLOGY REPORTS
- RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
- (2012) Fabienne Danhier et al. MOLECULAR PHARMACEUTICS
- Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
- (2012) Jun Yang et al. MOLECULAR PHARMACEUTICS
- Studies of Glutathione Transferase P1-1 Bound to a Platinum(IV)-Based Anticancer Compound Reveal the Molecular Basis of Its Activation
- (2011) Lorien J. Parker et al. CHEMISTRY-A EUROPEAN JOURNAL
- Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma
- (2011) Ilaria Zanellato et al. ChemMedChem
- The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells
- (2011) Ke Long Jin et al. Journal of Gynecologic Oncology
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- T Cell Ig and Mucin Domain Proteins and Immunity
- (2010) L. P. Kane JOURNAL OF IMMUNOLOGY
- Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes
- (2010) Michael R. Reithofer et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
- (2009) A Rocca et al. BRITISH JOURNAL OF CANCER
- Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells
- (2009) Hideharu Tatebe et al. CANCER LETTERS
- A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
- (2009) Darren Griffith et al. CHEMICAL COMMUNICATIONS
- Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
- (2009) P. Munster et al. CLINICAL CANCER RESEARCH
- Valproate, in Combination with Pemetrexed and Cisplatin, Provides Additional Efficacy to the Treatment of Malignant Mesothelioma
- (2009) F. Vandermeers et al. CLINICAL CANCER RESEARCH
- From signaling pathways to microtubule dynamics: the key players
- (2009) Sandrine Etienne-Manneville CURRENT OPINION IN CELL BIOLOGY
- Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting
- (2009) Katherine S. Lovejoy et al. DALTON TRANSACTIONS
- Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects
- (2009) Kamala Kesavan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy
- (2008) Sanjeev Shangary et al. Annual Review of Pharmacology and Toxicology
- Systemic Treatments for Mesothelioma: Standard and Novel
- (2008) Hedy Lee Kindler CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Suberoyl Bis-Hydroxamic Acid Activates Notch-1 Signaling and Induces Apoptosis in Medullary Thyroid Carcinoma Cells
- (2008) L. Ning et al. ONCOLOGIST
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started